Pharmaceutical

Thu, 17/09/2020 - 15:19
Falmouth, UK, 17th September 2020 / Sciad Newswire / Single-use technology has been touted as the latest and most promising development in bioprocessing technolog
Thu, 17/09/2020 - 12:00
The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R. Hayden, MD, PhD, to conduct PRidopidine Outcome On Function in Huntington’s Disease (PROOF-HD) clinical study. PROOF-HD is a global Phase 3, randomized, double-blind, placebo-controlled, parallel arm, multicenter study evaluating the efficacy and safety of pridopidine in patients with early stage HD.
Mon, 14/09/2020 - 13:00
London, UK, 14th September 2020 / Sciad Newswire / WEP Group Holdings Limited (WEP), a specialist CRO focused on delive
Wed, 02/09/2020 - 07:30
Edinburgh, UK, 2nd September 2020 / Sciad Newswire / Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage g
Certa Plus
Mon, 20/07/2020 - 07:30
Falmouth, UK, 20th July 2020 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) announces the launch of its new
Tue, 14/07/2020 - 11:00
San Diego, California and Saffron Walden, UK, 14th July 2020 / Sciad Newswire / Invivoscribe, Inc., an industry pioneer an
bioBoaVista Flexicon PF7
Mon, 22/06/2020 - 08:00
bioBoaVista, a Brazilian specialist culture media manufacturer for microbiological diagnosis, has developed a viral transport medium (MTV) for more efficient nasal tests for the
Ethernet WMFTG
Tue, 16/06/2020 - 07:30
Industry 4.0 connectivity offers fast and easy access to pump data with EtherNet/IP. Enhanced network control allows pump users to improve process performance and reduce operating costs
Dr Eddy Littler
Tue, 02/06/2020 - 08:00
Cambridge, UK, 2nd June 2020 / Sciad Newswire / Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of
Tue, 02/06/2020 - 06:00
Louvain-la-Neuve, Belgium, 2nd June 2020 / Sciad Newswire / 

Pages